Jonathan is an investment professional with more than 25 years experience at Vantage Consulting Group, where he has worked since graduating from the University of Virginia with a BA in Economics. He serves as Executive Vice President and Chief Investment Officer at Vantage. In this role he directs investment strategy, asset allocation, manager selection and portfolio construction; he regularly meets with and advises clients on the full spectrum of Vantage’s investment services.
Jonathan also serves on the board of managers of the Managing Member of New Ventures I, LLC, a venture capital fund investing in biotechnology related entities, and New Ventures Select, LLC, a pharmaceutical royalty fund, as well as the New Ventures III Managing Member board. In addition, he was a portfolio manager for the Lindner family of mutual funds from 1999-2001, serving as co-manager for the Small Cap and Asset Allocation funds. He currently serves on the board of directors of eReceivables Inc., a private US healthcare billing company and Solör Bioenergi Holdings AB, a private Swedish bioenergy company. He earned his Chartered Financial Analyst designation in 1999 and is a member of the CFA Institute.